Signaling Antagonism Helps Macrophages Identify Threats in Complex Ligand Mixtures

Macrophages are the sentinels of the innate immune system, patrolling tissues and continuously sampling their surroundings for signs of danger. In principle, their task sounds straightforward: detect a threat and respond. In practice, the challenge is staggering. A single infection can present a macrophage with a cocktail of molecular signals at once — fragments of bacterial cell walls, viral RNA mimics, bacterial DNA, and the host’s own inflammatory cytokines. Yet somehow the cell must figure out which threats are present and mount the appropriate response. A new study published in Molecular Systems Biology by Xiaolu Guo, Supriya Sen, Julian Gonzalez, and Alexander Hoffmann of the University of California, Los Angeles, tackles this problem head-on, and its central finding is delightfully counterintuitive: the immune system stays specific not despite interference between signaling pathways, but partly because of it.

The research focuses on nuclear factor kappa B, or NFκB, the master transcription factor that activates immune genes in macrophages. Decades of work have established that NFκB does not simply switch on and off. Instead, it shuttles in and out of the nucleus with distinctive temporal patterns — oscillatory for some stimuli, transient for others — and these dynamic signatures, sometimes called signaling codons, carry information about which ligand triggered the response. Six such codons have been characterized: activation speed, peak amplitude, duration of signaling, total integral activity, the balance of early versus late activity, and oscillatory content. Together, they form something like a Morse code of immunity, allowing the cell to distinguish, for example, a cytokine signal from a bacterial lipopolysaccharide encounter.

The problem with most previous studies, the authors note, is that they examined one ligand at a time. Nature rarely cooperates so neatly. During an E. coli infection, a macrophage may first encounter LPS from the bacterial envelope, then CpG DNA from the ruptured genome, and simultaneously inflammatory TNF produced by neighboring cells. In the gut, immune cells confront a rolling storm of microbial and host-derived signals. The combinatorial space of possible ligand mixtures is astronomically large, making comprehensive experimental exploration essentially impossible. The UCLA team’s solution was to build a virtual laboratory: a mechanistic mathematical model of NFκB signaling, comprising 52 ordinary differential equations, 101 reactions, and 133 parameters, organized into five receptor modules corresponding to the TNF, TLR2, TLR4, TLR9, and TLR3 pathways, all converging on a shared IKK–IκBα–NFκB core.

Crucially, the model was not trained on mixture data. It was fitted to live-cell imaging trajectories of hundreds of individual macrophages responding to each of five ligands — TNF, LPS, Pam3CSK4, CpG, and poly(I:C) — at multiple doses. To extend the model into combinatorial territory, the researchers developed an elegant statistical workaround. Because each simulated cell’s parameters had only been estimated for one receptor module plus the shared core, they imputed the missing receptor parameters using nearest-neighbor hot-deck imputation, anchoring each match on the core module parameters that all pathways share. In this way, the team generated virtual cell populations capable of responding to any ligand combination — thirty-one conditions in total, spanning single ligands through the full five-ligand cocktail.

The first validation was encouraging. Experimental responder fractions, measured by live-cell microscopy of fluorescently tagged RelA, rose with the number of ligands present and plateaued much as the model predicted, suggesting that signaling from multiple ligands generally combines in an integrative fashion and that non-responding cells reflect receptor-level heterogeneity rather than cellular ill-health. But one prediction failed in a telling way. The model expected the CpG plus poly(I:C) combination to produce a stronger response than either ligand alone; the experiments showed the opposite, with the pair dampening signaling below the CpG-only level. That discrepancy became the thread the researchers pulled to unravel a previously unknown mechanism.

Both CpG and poly(I:C) are sensed by Toll-like receptors located in endosomes, and both depend on the same endosomal transport machinery to reach those receptors. The original model had treated these transport processes as independent, but reality is stingier: the cell has a finite capacity for hauling cargo into endosomes. By reformulating the transport reactions with competitive Michaelis–Menten kinetics — adding no new parameters — the researchers captured the bottleneck. The result was a negative correlation between CpG–TLR9 and pIC–TLR3 signaling complexes: because poly(I:C) signals relatively weakly, it effectively poisons the stronger CpG response by saturating their shared transport pathway. The revised model accurately reproduced the non-integrative experimental result.

With the model refined, the team asked whether ligand identity remains readable within mixtures. Using Wasserstein distance analysis and machine learning classifiers trained on the six signaling codons, they found that specificity does degrade as ligands pile up — the five-ligand condition was hardest to classify — but it never vanished. Even the five-ligand mixture was recognized well above chance. More strikingly, binary classifiers asked a biologically natural question: is this ligand present in the mixture at all? For TNF, the answer could be read from NFκB dynamics with an ROC area under the curve of 0.94; LPS and Pam followed closely, and experimental data confirmed the pattern. Macrophages, it appears, can partially detect specific threats even in a molecular crowd.

To map synergy and antagonism systematically, the team simulated roughly 360,000 single-cell trajectories across all ten ligand pairs at six doses each. Synergy emerged mainly at low doses and traced back to ultrasensitive IKK activation: in cells with low receptor abundance and constrained TAK1 signaling, two weak inputs could combine to push the ultrasensitive IKK switch over threshold, amplifying NFκB peaks. Antagonism, by contrast, arose at high doses through resource competition. For the LPS–Pam pair, the shared co-receptor CD14 proved to be the limiting resource. Pam binds and releases CD14 more rapidly, peaking early and sequestering the co-receptor before LPS signaling can fully mature, thereby diverting CD14 away from productive TLR4 signaling and weakening the downstream NFκB response.

The most consequential discovery concerned what these interactions do for stimulus-response specificity. When the researchers compared a model lacking CpG–pIC antagonism with the updated model that includes it, the antagonistic version showed significantly greater separability between conditions in Wasserstein distance analyses. Multidimensional scaling visualizations made the point vividly: without competition, the CpG–pIC condition drifted into the cluster of other mixtures, becoming just another blended signal. With competition included, it stood apart, carrying a distinctive dynamic fingerprint. Antagonism, born of a mundane biochemical bottleneck, was actively manufacturing uniqueness. Synergy, though dramatic at the single-cell level, did not confer any similar benefit — it boosted peak responses without improving the distinguishability of the informative signaling codons.

The implications reach well beyond this particular pair of ligands. Resource-limited antagonism — competition for endosomal transport, for co-receptors like CD14, or for shared kinase modules — may represent a general design principle by which immune signaling networks preserve information under combinatorial overload. The computational workflow itself is a contribution: by combining mechanistic ordinary differential equation models with nonlinear mixed-effects parameter estimation and anchor-based statistical matching, the team demonstrated a path toward virtual cell models that retain single-cell heterogeneity while extending predictions far beyond their training data. With all code and data released openly, the framework is ready to absorb additional pathways such as AP1, p38, and the interferon axis, and to explore sequential stimulation over longer timescales. For now, the message is clear: in the immune system’s crowded molecular marketplace, a little rivalry among signals may be exactly what keeps the message intelligible.

Subject of Research: How signaling pathway antagonism shapes macrophage stimulus-response specificity to mixtures of immune ligands

Article Title: Macrophage response specificity to ligand mixtures is improved by signaling pathway antagonism

Article References: Guo, X., Sen, S., Gonzalez, J., & Hoffmann, A. (2026). Macrophage response specificity to ligand mixtures is improved by signaling pathway antagonism. Molecular Systems Biology. https://doi.org/10.1038/s44320-026-00230-9

Image Credits: AI Generated

DOI: 10.1038/s44320-026-00230-9

Keywords: macrophages, NF-kB, signaling dynamics, Toll-like receptors, stimulus-response specificity, ligand mixtures, mathematical modeling, systems biology, innate immunity, antagonism, synergy, single-cell imaging